Sirius XM Issued Higher Estimates and 4 Stock Analyses Sparking Chatter
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): After reviewing a presentation on phase II data from a combination of Vertex’s ’809 and Kalydeco, Wells Fargo believes that that the combination showed signs of producing significant improvement in patients. The firm did find disappointment that there was no meaningful dose dependence between the 200mg and 400mg of the drug which could have suggested that higher doses would result in greater benefits. The firm keeps its Outperform rating on the stock.
SIRIUS XM Radio Inc. (NASDAQ:SIRI) sub estimates have been increased by Bank of America because of strong auto sales along with Q3 sub adds. Shares have a Buy rating.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Dollar Tree, Inc. (NASDAQ:DLTR): After Dollar Tree was guided to the low end of its comp guidance but but claimed it still had the ability to make the middle of its EPS guidance, Wells Fargo views some of the company’s announcements as upbeat news, as it also included early positive results from its coupon initiative. According to the firm, the stock may be a little volatile until comps stabilize, but it keeps its Outperform rating on the stock.
Oshkosh Corporation (NYSE:OSK) has a worth of $42-$49 in sum-of-parts valuation, according to Bank of America Merrill Lynch.
Jive Software, Inc. (NASDAQ:JIVE): According to UBS, the JiveWorld user conference had good attendance and the firm confirmed Jive’s strong positioned in the high-end of enterprise-class social collaboration software. The firm believes that the company has compelling valuation, and it keeps its Buy rating and $20 price target on the stock.